BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 220842)

  • 1. On certain relationships between gamma-aminobutyric acid (GABA) and dopaminergic agents in pentylenetetrazol convulsions.
    Roussinov KS; Lazarova MB
    Acta Physiol Pharmacol Bulg; 1978; 4(3):43-9. PubMed ID: 220842
    [No Abstract]   [Full Text] [Related]  

  • 2. On certain effects of dopaminergic agents in pentylenetetrazol convulsions.
    Lazarova MB; Roussinov KS
    Acta Physiol Pharmacol Bulg; 1978; 4(3):50-5. PubMed ID: 751452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On some relationships between dopaminergic and serotoninergic mechanisms in pentylenetetrazol convulsions in albino mice.
    Lazarova M; Roussinov K
    Acta Physiol Pharmacol Bulg; 1979; 5(3):67-74. PubMed ID: 317212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission.
    Georgiev VP; Markovska VL; Petkova BP
    Acta Physiol Pharmacol Bulg; 1978; 4(3):56-64. PubMed ID: 220843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On certain relationships between gamma-aminobutyric acid (GABA) and adrenergic mechanisms in convulsive-seizure reaction.
    Roussinov KS; Lazarova MB; Atanassova-shopova S
    Acta Physiol Pharmacol Bulg; 1976; 2(3):69-76. PubMed ID: 189573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dopaminergic and GABA-ergic interactions in seizure susceptibility.
    György L
    Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):280-6. PubMed ID: 526081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
    Markovska V; Georgiev V
    Acta Physiol Pharmacol Bulg; 1982; 8(3):67-73. PubMed ID: 6820612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the relationships between the neurotransmitter systems in the convulsive-seizure reactions.
    Lazarova M; Roussinov K
    Acta Physiol Pharmacol Bulg; 1982; 8(1-2):78-83. PubMed ID: 6126997
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of dopaminergic and noradrenergic mechanisms in Metrazole convulsions in mice.
    Dadkar VN; Dahanukar SA; Sheth UK
    Indian J Med Res; 1979 Sep; 70():492-4. PubMed ID: 535961
    [No Abstract]   [Full Text] [Related]  

  • 10. On some relationships between gamma-aminobutyric acid (GABA) and the cholinergic mechanisms in pentylenetetrazol convulsions.
    Roussinov K; Lazarova M
    Acta Physiol Pharmacol Bulg; 1977; 3(4):28-36. PubMed ID: 614763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combined treatment with dopaminergic and GABA-ergic drugs on the threshold for maximal electroconvulsions in mice.
    Czuczwar SJ
    Pol J Pharmacol Pharm; 1981; 33(1):25-35. PubMed ID: 6265890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dopaminergic component in the mechanism of action of gamma-aminobutyric acid derivatives and structural analogs].
    Allikmets LKh; Polevoĭ LG; Tsareva TA; Zharkovskiĭ AM
    Farmakol Toksikol; 1979; 42(6):603-6. PubMed ID: 499466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of GABA-linoleamide and glycine linoleamide on pentamethylenetetrazole convulsions].
    Vamvakidès A
    J Pharmacol; 1986; 17(3):323-7. PubMed ID: 3025524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On some relationships between GABA-ergic and 5-HT-ergic mechanisms in pentylenetetrazol convulsive-seizure reactions.
    Lazarova M; Roussinov K; Kleinrok Z; Rajtar G
    Agressologie; 1980; 21(5):253-7. PubMed ID: 7246912
    [No Abstract]   [Full Text] [Related]  

  • 15. Brain dopamine and seizure susceptibility in mice.
    Kleinrok Z; Czuczwar S; Wójcik A; Przegaliński E
    Pol J Pharmacol Pharm; 1978; 30(4):513-9. PubMed ID: 740553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of pentylenetetrazol kindling of epileptogenesis in rats by dopaminergic agents.
    Mehta VL; Bhalla S; Wafai ZA
    Zhongguo Yao Li Xue Bao; 1988 Jan; 9(1):7-11. PubMed ID: 3188938
    [No Abstract]   [Full Text] [Related]  

  • 17. [The pharmacological differences between kynurenine- and korazol-induced seizures (the participation of GABA-B receptors and dopamine)].
    Lapin IP
    Eksp Klin Farmakol; 1998; 61(2):20-2. PubMed ID: 9621167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
    Worms P; Depoortere H; Durand A; Morselli PL; Lloyd KG; Bartholini G
    J Pharmacol Exp Ther; 1982 Mar; 220(3):660-71. PubMed ID: 6278129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dopaminergic and GABA-ergic drugs given alone or in combination on the anticonvulsant action of phenobarbital and diphenylhydantoin in the electroshock test in mice.
    Kleinrok Z; Czuczwar SJ; Kozicka M
    Epilepsia; 1980 Oct; 21(5):519-29. PubMed ID: 6252007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant characteristics of pyridoxyl-gamma-aminobutyrate, PL-GABA.
    Kang TC; Kang JH; Kim HT; Lee SJ; Choi UK; Kim JE; Kwak SE; Kim DW; Choi SY; Kwon OS
    Neuropharmacology; 2008 May; 54(6):954-64. PubMed ID: 18346762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.